Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.27B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.23B |
| 3 |
SPDR Gold Trust
GLD
|
+$710M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$662M |
| 5 |
Abbott
ABT
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$932M |
| 3 |
TransDigm Group
TDG
|
+$833M |
| 4 |
MPLX
MPLX
|
+$616M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.4% |
| 2 | Financials | 10.07% |
| 3 | Consumer Discretionary | 8.39% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPF
3826
John Hancock Preferred Income Fund II
HPF
$344M
| $2.25M | ﹤0.01% |
112,225
+650
| +0.6% | +$13.2K |
|
3827
TG Therapeutics
TGTX
$7.64B
| $2.25M | ﹤0.01% |
158,116
-21,461
| -12% | -$274K |
|
|
ZF
3828
DELISTED
Virtus Total Return Fund Inc.
ZF
| $2.24M | ﹤0.01% |
199,419
-5,892
| -3% | -$67.6K |
|
3829
V2X
VVX
$2.44B
| $2.23M | ﹤0.01% |
60,025
+10,671
| +22% | +$345K |
|
3830
Andersons Inc
ANDE
$2.38B
| $2.23M | ﹤0.01% |
67,349
-34,688
| -34% | -$1.18M |
|
3831
ICF International
ICFI
$1.54B
| $2.23M | ﹤0.01% |
38,132
-30,503
| -44% | -$1.72M |
|
3832
Unisys
UIS
$214M
| $2.23M | ﹤0.01% |
206,991
+80,945
| +64% | +$814K |
|
|
KANG
3833
DELISTED
iKang Healthcare Group, Inc.
KANG
| $2.22M | ﹤0.01% |
111,390
+70,247
| +171% | +$1.18M |
|
|
HIE
3834
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $2.22M | ﹤0.01% |
194,425
+52,797
| +37% | +$657K |
|
3835
Fate Therapeutics
FATE
$303M
| $2.21M | ﹤0.01% |
226,651
-292,411
| -56% | -$2.8M |
|
|
ADAM
3836
Adamas Trust
ADAM
$848M
| $2.21M | ﹤0.01% |
93,142
+2,449
| +3% | +$57.4K |
|
3837
Shore Bancshares
SHBI
$814M
| $2.21M | ﹤0.01% |
117,106
+199
| +0.2% | +$3.57K |
|
|
FAZ
3838
Direxion Daily Financial Bear 3x ETF
FAZ
$84.8M
| $2.21M | ﹤0.01% |
195,062
+2,514
| +1% | +$28.5K |
|
3839
Foster
FSTR
$438M
| $2.21M | ﹤0.01% |
93,691
+27,570
| +42% | +$712K |
|
|
HPI
3840
John Hancock Preferred Income Fund
HPI
$432M
| $2.2M | ﹤0.01% |
107,631
-21,016
| -16% | -$433K |
|
|
IPHS
3841
DELISTED
Innophos Holdings, Inc.
IPHS
| $2.2M | ﹤0.01% |
54,803
-44,033
| -45% | -$1.93M |
|
|
QUOT
3842
DELISTED
Quotient Technology Inc
QUOT
| $2.2M | ﹤0.01% |
167,993
-416,568
| -71% | -$5.27M |
|
|
NXGN
3843
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.2M | ﹤0.01% |
161,198
-43,980
| -21% | -$579K |
|
3844
Appian
APPN
$2.2B
| $2.19M | ﹤0.01% |
87,158
-14,584
| -14% | -$442K |
|
3845
STAAR Surgical
STAA
$1.14B
| $2.19M | ﹤0.01% |
148,309
-17,923
| -11% | -$280K |
|
3846
BJ's Restaurants
BJRI
$1.44B
| $2.19M | ﹤0.01% |
48,843
-53,535
| -52% | -$2.16M |
|
|
FLG.PRU
3847
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$117M
| $2.19M | ﹤0.01% |
43,952
+12,599
| +40% | +$633K |
|
|
ECHO
3848
DELISTED
Echo Global Logistics, Inc.
ECHO
| $2.19M | ﹤0.01% |
79,425
-148,069
| -65% | -$4.16M |
|
|
ONDK
3849
DELISTED
On Deck Capital, Inc.
ONDK
| $2.19M | ﹤0.01% |
391,793
+274,504
| +234% | +$1.4M |
|
3850
Limoneira
LMNR
$249M
| $2.19M | ﹤0.01% |
92,204
+5,100
| +6% | +$110K |
|
Similar funds
Morgan Stanley's Q1 2018 Portfolio in Review
As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
- Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
- Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
- Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
- Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
- Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
- Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.
Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.